Mydecine On Verge Of Finalizing Spin-Out Of Cannabis Subsidiaries, Obtains Shareholder And Court Approval

Psychedelics and mycology company Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) is poised to wrap up the spin-out of its U.S. cannabis assets into a newly formed subsidiary.

The Denver-based company announced Friday it has received shareholders' approval for the transaction at its annual general and special shareholders meeting the last week. The company's shareholders voted 99% in favor of approving a statutory plan of arrangement between Mydecine and ALT House Cannabis Inc.

In addition, the company obtained final approval from the Supreme Court of …

Full story available on Benzinga.com

More Mydecine On Verge Of Finalizing Spin-Out Of Cannabis Subsidiaries, Obtains Shareholder And Court Approval